Prurigo Nodularis
📧 Sign up to get email alerts when something new happens for Prurigo Nodularis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Study on the Treatment of Prurigo Nodularis With Stapokibart Injection [Phase 3]
A Phase 3 clinical trial evaluating stapokibart injection for prurigo nodularis has completed.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases [Phase 1]
BeiGene is conducting a Phase 1 trial to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single- and multiple-asc…
-
EMA approval · 2026-04-20EMA Authorised: Dupixent (dupilumab) — Sanofi Winthrop Industrie
The EMA authorised Dupixent (dupilumab) for multiple EU indications, including atopic dermatitis, prurigo nodularis, eosinophilic esophagiti…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) [Phase 3]
A Phase 3 clinical trial evaluating povorcitinib for prurigo nodularis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1) [Phase 3]
Phase 3 clinical trial evaluating povorcitinib for efficacy and safety in participants with prurigo nodularis; the study is currently recrui…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis [Phase 2]
Phase 2 clinical trial update for ICP-332 in Prurigo nodularis. The study is currently recruiting to evaluate efficacy and safety.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
This clinical-trial update describes real-world use of nemolizumab in adults with moderate-to-severe prurigo nodularis and indicates recruit…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study of Barzolvolimab in Patients With Prurigo Nodularis [Phase 2]
This entry notes a Phase 2 clinical trial of Barzolvolimab for prurigo nodularis and indicates the study is currently not actively recruitin…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis [Phase 3]
An update on Amgen's Phase 3, double-blind, placebo-controlled trial of rocatinlimab for prurigo nodularis, currently active but not recruit…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis [Phase 3]
A Phase 3 study evaluating the pharmacokinetics and safety of dupilumab in children aged 6 months to under 18 years with prurigo nodularis; …
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis [Phase 2]
Phase 2 study evaluating the efficacy, safety, and tolerability of vixarelimab in reducing pruritus for patients with prurigo nodularis has …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis
This clinical trial update examines the early and long-term efficacy and immune changes of dupilumab in prurigo nodularis. The study is curr…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of ruxolitinib cream in prurigo nodularis has completed and results have been posted.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life [NA]
Clinical trial update noting the completion of a study evaluating the EMD Protocol for Urge and its effect on dermatology-specific quality o…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) [Phase 3]
Phase 3 trial evaluating the safety and efficacy of ruxolitinib topical cream for prurigo nodularis has completed with results posted.
-
CLINICAL_TRIALS other · 2025-11-12Clinical Trial Update: A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) [Phase 3]
This clinical trial update notes that the long-term Phase 3 study of nemolizumab (CD14152) for prurigo nodularis is currently active but not…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study
This document reports real-world observational findings on the effectiveness of dupilumab in patients with prurigo nodularis. The study is c…
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating the safety and tolerability of maximal-use ruxolitinib cream…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
An observational, non-interventional study evaluating long-term dupilumab treatment, safety, and patient-reported outcomes in chronic nodula…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Determinants of Chronic Inflammatory Skin Disease Trajectories
An ongoing clinical study is investigating determinants of chronic inflammatory skin disease trajectories, spanning multiple conditions such…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: PRISM Study-Pruritus Relief Through Itch Scratch Modulation [Phase 2, Phase 3]
The PRISM study evaluated pruritus relief through itch-scratch modulation in prurigo nodularis and has completed Phase 2/3. Results have bee…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Efficacy of Topical Cannabidiol for Eczema [Phase 2]
A Phase 2 clinical trial sponsored by Khon Kaen University is evaluating the efficacy of a topical cannabidiol formulation for eczema-relate…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Study on the Treatment of Prurigo Nodularis With Stapokibart Injection [Phase 3]
A Phase 3 trial of Stapokibart Injection for Prurigo nodularis is listed as active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis [Phase 3]
Phase 3 clinical trial of MG-K10, a humanized monoclonal antibody injection, for prurigo nodularis is currently recruiting.
-
CLINICAL_TRIALS other · 2025-01-15Clinical Trial Update: Upadacitinib for Prurigo Nodularis [Phase 4]
Upadacitinib is being studied in Phase 4 for Prurigo Nodularis and is currently recruiting; sponsor is Psoriasis Treatment Center of Central…